Encompass Health Corporation (EHC)

NYSE: EHC · Real-Time Price · USD

125.81

+0.58 (0.46%)

At close: Aug 10, 2026, 4:00 PM EDT

126.57

+0.76 (0.60%)

After-hours: Aug 10, 2026, 7:34 PM EDT

Encompass Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	833.3	759.1	596.6	463	365.9	517.2
Depreciation & Amortization	346.5	327.9	299.6	273.9	243.6	219.6
Stock-Based Compensation	58	56.5	48.3	50.6	29.2	29.1
Other Adjustments	2	28.2	36.7	17	60.4	22.8
Change in Receivables	-62.9	-15.2	3	-22.4	-16.9	-39.5
Changes in Accounts Payable	0.2	-22.6	3	11.8	2.3	15.6
Changes in Accrued Expenses	-	15.9	20.4	39.2	-31.2	-30.4
Changes in Other Operating Activities	13.3	26.2	-4.5	21.7	15.4	-55.6
Operating Cash Flow	1,213	1,176	1,003	850.8	705.8	715.8
Operating Cash Flow Growth	9.69%	17.23%	17.87%	20.54%	-1.40%	1.57%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-799.1	-736.4	-642.5	-583.1	-584.1	-545.7
Purchases of Investments	-111.1	-184.4	-22.5	-23	-35.2	-9
Proceeds from Sale of Investments	100.4	172.8	18.9	7.4	-	-
Other Investing Activities	-16.6	-16.6	-7.2	-4.1	-4.2	7.6
Investing Cash Flow	-826.4	-764.6	-653.3	-602.8	-627	-666.3

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Short-Term Debt Issued	820	210	80	60	240	300
Short-Term Debt Repaid	-620	-100	-60	-115	-385	-100
Net Short-Term Debt Issued (Repaid)	200	110	20	-55	-145	200
Long-Term Debt Issued	-	-	15	20	11.8	-
Long-Term Debt Repaid	-516.2	-115.1	-255.2	-7.2	-345.8	-214.5
Net Long-Term Debt Issued (Repaid)	-516.2	-115.1	-240.2	12.8	-334	-214.5
Repurchase of Common Stock	-247	-158	-31.1	-	-	-
Net Common Stock Issued (Repurchased)	-247	-158	-31.1	-	-	-
Common Dividends Paid	-75.2	-71.1	-62.8	-60.4	-99	-112.2
Other Financing Activities	-241.6	-197	-16.5	-94.6	-82.8	-103.2
Financing Cash Flow	-390	-431.2	-330.6	-197.2	-145.7	-240.1

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash Flow	-3.9	-20.2	18.9	50.8	-66.9	-190.6

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	413.4	439.2	360.3	267.7	121.7	170.1
Free Cash Flow Growth	-5.87%	21.90%	34.59%	119.97%	-28.45%	-45.46%
FCF Margin	6.66%	7.40%	6.71%	5.58%	2.80%	4.24%
Free Cash Flow Per Share	4.08	4.30	3.53	2.64	1.21	1.70
Levered Free Cash Flow	-134.3	172.1	-88.5	73.3	-560.7	3
Unlevered Free Cash Flow	449.37	450.94	367.28	335.97	136.26	129.84

SEC Filings: 10-K · 10-Q